BRIGHTSPRING HEALTH SERVICES
BTSGNASDAQTrading Snapshot
- Day Range
- $54.88 – $56.21
- 52-Week Range
- $26.28 – $73.75
- Volume
- $2.63B
- Avg Volume
- $2.91B
- Shares Outstanding
- 197.3M
- Next Earnings
- Dec 2, 2026
Fundamentals Snapshot
- Annual Revenue
- $12.91B
- Last Q Revenue
- $3.87B
- P/E Ratio
- 30.6
- P/S Ratio
- 0.8x
- EPS (TTM)
- $1.66
- Dividend Yield
- —
- Dilution (1yr)
- +2.5%
Why Investors Own BTSG
- ✓High-growth profile — revenue up +53.7% YoY with expanding US Equity exposure.
- ✓Healthy economics — 29% gross margin and 8% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
BRIGHTSPRING HEALTH SERVICES
BTSG
StockOtter · stockotter.spaceAbout BRIGHTSPRING HEALTH SERVICES
BrightSpring Health Services, Inc. operates across the United States, offering a range of healthcare solutions directly within patients' homes and local communities. The company's extensive platform focuses on providing crucial pharmacy and medical provider services, including both clinical care and supportive assistance, to individuals covered by Medicare, Medicaid, and private insurance. Patients receive care from a dedicated team of clinical professionals and licensed pharmacists. Formerly known as Phoenix Parent Holdings Inc., the company officially adopted the name BrightSpring Health Services, Inc. in May 2021. Founded in 1974, its headquarters are located in Louisville, Kentucky.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Analyst Ratings
ⓘLatest News & Updates
BrightSpring Health Targets Growth Through Specialty Pharmacy, M&A and AI
BrightSpring Health Services (NASDAQ: BTSG) outlined its growth strategy across pharmacy and provider services at the Bernstein healthcare services conference, emphasizing specialty pharmacy expansion, home health acquis
Will M&A Be the Next Growth Factor as BTSG's Cash Flow and Leverage Improve?
BTSG's stronger cash flow and lower leverage could give it more flexibility to pursue acquisitions and support future growth.
Best Momentum Stocks to Buy for September 24th
RDVT, BTSG and THC made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on September 24th, 2026.
3 Momentum Anomaly Stocks to Buy as Markets Surge on AI Rally
Centene, BrightSpring and Delek combine 52-week gains with short-term pullbacks, putting them in focus as momentum plays for volatile markets.
BTSG Faces $200M IRA Hit but Efficiency May Protect Profitability
BTSG faces a $200M 2026 IRA revenue headwind in Home Pharmacy, but efficiency gains and technology are helping protect profitability.
BrightSpring Health Services, Inc. (BTSG) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
BrightSpring Health Services, Inc. (BTSG) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript